Brief: Citius Oncology Signs U.S. Distribution Agreement With Mckesson To Support Lymphir Commercial Launch
20/10/2025 13:44
Oct 20 (Reuters) - Citius Oncology Inc CTOR.O: CITIUS ONCOLOGY SIGNS U.S. DISTRIBUTION AGREEMENT WITH MCKESSON TO SUPPORT LYMPHIR™ COMMERCIAL LAUNCH CITIUS ONCOLOGY INC - LYMPHIR COMMERCIAL LAUNCH PLANNED FOR Q4 2025 Source text: ID:nPn15xXh8a Further company coverage: CTOR.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Citius Pharmaceuticals
See all newsCitius Pharmaceuticals Q2 revenue rises on LYMPHIR launch
Citius Pharmaceuticals reports first revenue of $3.9 mln
Brief: Citius Oncology Expands International Distribution Of Lymphir™ To European Union Through Exclusive Agreement With Uniphar
Brief: Citius Pharmaceuticals, Inc. Reports Fiscal Year 2025 Financial Results And Provides Business Update
Brief: Citius Oncology Announces $18 Million Concurrent Registered Direct Offering And Private Placement Priced At-The-Market Under Nasdaq Rules